SANKYO C22 (Benicar HCT 12.5 mg / 20 mg)
Generic Name: hydrochlorothiazide/olmesartan
Pill imprint SANKYO C22 has been identified as Benicar HCT 12.5 mg / 20 mg.
Benicar HCT is used in the treatment of high blood pressure and belongs to the drug class antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Benicar HCT 12.5 mg / 20 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for SANKYO C22 (Benicar HCT 12.5 mg / 20 mg)
- Generic Name:
- 12.5 mg / 20 mg
- 9.00 mm
- Prescription only
- Drug Class:
- Antihypertensive combinations
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Sankyo Pharma
- National Drug Code (NDC):
- Inactive Ingredients:
- hydroxypropyl cellulose
low substituted hydroxypropyl cellulose
ferric oxide red
ferric oxide yellow
|NDC Code||Manufacturer / Repackager|
|54868-5170||Physicians Total Care Inc (repackager)|
|35356-0256||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.